Literature DB >> 21717155

Analysis of different medulloblastoma histotypes by two-dimensional gel and MALDI-TOF.

Cristina Zanini1, Giorgia Mandili, Daniele Bertin, Francesco Cerutti, Denisa Baci, Marco Leone, Isabella Morra, Luca di Montezemolo Cordero, Marco Forni.   

Abstract

OBJECTIVE: The purpose of this study is to detect different protein profiles in medulloblastoma (MDB) that may be clinically relevant and to check the correspondence of histological classification of MDB with proteomic profiles.
MATERIALS AND METHODS: Surgical specimens, snap frozen at the time of neurosurgery, entered the proteomic study. Eight samples from patients (age range, 4 months-26 years) with different MDB histotypes (five classic, one desmoplastic/nodular, one with extensive nodularity, and one anaplastic) were analyzed by two-dimensional gel electrophoresis. One sample for each histotype was further characterized by matrix-assisted laser desorption/ionization time of flight mass spectrometry analysis.
RESULTS: Eighty-six unique proteins were identified and compared to histology, with the determination of proteins expressed by single histotypes and of a smaller number of proteins shared by two or three histotypes. The sharp difference of protein expression was found to be in agreement with WHO histological classification, with the identification of type-specific proteins with limited overlapping between histotypes.
CONCLUSION: Proteomic analysis confirmed and strengthened the difference between histotypes as biologically relevant. Cluster analysis enhanced the distance of extensive nodularity MDB from other histotypes. Possible innovative approaches to therapy may rely upon a proteomic-based classification of MDB tightly correlated to histology. The utility of snap freezing tumoral samples must be stressed and should become a mandatory task for pathologists.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21717155     DOI: 10.1007/s00381-011-1515-9

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  18 in total

1.  Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables.

Authors:  David W Ellison; Mehmet Kocak; James Dalton; Hisham Megahed; Meryl E Lusher; Sarra L Ryan; Wei Zhao; Sarah Leigh Nicholson; Roger E Taylor; Simon Bailey; Steven C Clifford
Journal:  J Clin Oncol       Date:  2010-10-04       Impact factor: 44.544

2.  The proteasome--an emerging therapeutic target in cancer.

Authors:  Beverly S Mitchell
Journal:  N Engl J Med       Date:  2003-06-26       Impact factor: 91.245

Review 3.  Glioma pathophysiology: insights emerging from proteomics.

Authors:  Ruth F Deighton; Richard McGregor; Jocelyn Kemp; James McCulloch; Ian R Whittle
Journal:  Brain Pathol       Date:  2010-01-13       Impact factor: 6.508

4.  Protein/RNA coextraction and small two-dimensional polyacrylamide gel electrophoresis for proteomic/gene expression analysis of renal cancer biopsies.

Authors:  Giovanna Barbero; Franco Carta; Giuliana Giribaldi; Giorgia Mandili; Salvatore Crobu; Carlo Ceruti; Dario Fontana; Paolo Destefanis; Francesco Turrini
Journal:  Anal Biochem       Date:  2005-11-02       Impact factor: 3.365

5.  Molecular biology of medulloblastoma: will it ever make a difference to clinical management?

Authors:  Richard J Gilbertson; Amar Gajjar
Journal:  J Neurooncol       Date:  2005-12       Impact factor: 4.130

6.  Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis.

Authors:  Stefan Rutkowski; Katja von Hoff; Angela Emser; Isabella Zwiener; Torsten Pietsch; Dominique Figarella-Branger; Felice Giangaspero; David W Ellison; Maria-Luisa Garre; Veronica Biassoni; Richard G Grundy; Jonathan L Finlay; Girish Dhall; Marie-Anne Raquin; Jacques Grill
Journal:  J Clin Oncol       Date:  2010-10-12       Impact factor: 44.544

7.  Large cell/anaplastic medulloblastoma: outcome according to myc status, histopathological, and clinical risk factors.

Authors:  Katja von Hoff; Wolfgang Hartmann; André Oscar von Bueren; Nicolas Ulrich Gerber; Michael Andreas Grotzer; Torsten Pietsch; Stefan Rutkowski
Journal:  Pediatr Blood Cancer       Date:  2010-03       Impact factor: 3.167

8.  Necdin, a Prader-Willi syndrome candidate gene, regulates gonadotropin-releasing hormone neurons during development.

Authors:  Nichol L G Miller; Rachel Wevrick; Pamela L Mellon
Journal:  Hum Mol Genet       Date:  2008-10-17       Impact factor: 6.150

9.  Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy.

Authors:  A S Polans; D Witkowska; T L Haley; D Amundson; L Baizer; G Adamus
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

Review 10.  Galectins and gliomas.

Authors:  Marie Le Mercier; Shannon Fortin; Véronique Mathieu; Robert Kiss; Florence Lefranc
Journal:  Brain Pathol       Date:  2009-04-07       Impact factor: 6.508

View more
  6 in total

1.  Core Canonical Pathways Involved in Developing Human Glioblastoma Multiforme (GBM).

Authors:  Somiranjan Ghosh; Sisir Dutta; Gabriel Thorne; Ava Boston; Alexis Barfield; Narendra Banerjee; Rayshawn Walker; Hirendra Nath Banerjee
Journal:  Int J Sci Res Sci Eng Technol       Date:  2017-02-01

2.  Differentiation of mesenchymal stem cells derived from pancreatic islets and bone marrow into islet-like cell phenotype.

Authors:  Cristina Zanini; Stefania Bruno; Giorgia Mandili; Denisa Baci; Francesco Cerutti; Giovanna Cenacchi; Leo Izzi; Giovanni Camussi; Marco Forni
Journal:  PLoS One       Date:  2011-12-16       Impact factor: 3.240

3.  Cluster and Principal Component Analysis of Human Glioblastoma Multiforme (GBM) Tumor Proteome.

Authors:  Mehdi Pooladi; Mostafa Rezaei-Tavirani; Mehrdad Hashemi; Saeed Hesami-Tackallou; Solmaz Khaghani-Razi-Abad; Afshin Moradi; Ali Reza Zali; Masoumeh Mousavi; Leila Firozi-Dalvand; Azadeh Rakhshan; Mona Zamanian Azodi
Journal:  Iran J Cancer Prev       Date:  2014

Review 4.  A Proteogenomic Approach to Understanding MYC Function in Metastatic Medulloblastoma Tumors.

Authors:  Jerome A Staal; Yanxin Pei; Brian R Rood
Journal:  Int J Mol Sci       Date:  2016-10-19       Impact factor: 5.923

5.  Medullospheres from DAOY, UW228 and ONS-76 cells: increased stem cell population and proteomic modifications.

Authors:  Cristina Zanini; Elisabetta Ercole; Giorgia Mandili; Roberta Salaroli; Alice Poli; Cristiano Renna; Valentina Papa; Giovanna Cenacchi; Marco Forni
Journal:  PLoS One       Date:  2013-05-24       Impact factor: 3.240

6.  Top-down proteomic characterization of DAOY medulloblastoma tumor cell line.

Authors:  Claudia Martelli; Luca D'Angelo; Marta Barba; Mirko Baranzini; Ilaria Inserra; Federica Iavarone; Federica Vincenzoni; Gianpiero Tamburrini; Luca Massimi; Concezio Di Rocco; Massimo Caldarelli; Irene Messana; Fabrizio Michetti; Massimo Castagnola; Wanda Lattanzi; Claudia Desiderio
Journal:  EuPA Open Proteom       Date:  2016-04-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.